Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculty of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.
Bioorg Med Chem Lett. 2012 Jun 15;22(12):3993-7. doi: 10.1016/j.bmcl.2012.04.093. Epub 2012 Apr 28.
The synthesis, inhibitory activity and mode of action of oxazolidine-2,4-diones against porcine pancreatic elastase, here used as a model for human neutrophil elastase, are reported. The nature of N-substitution at the oxazolidine-2,4-dione scaffold has large effect on the inhibitory potency against elastase. N-Acyl and N-sulfonyloxazolidine-2,4-diones emerged as potent pseudo-irreversible inhibitors, displaying high second-order rate constants for PPE inactivation. The title compounds were also shown to be potent inhibitors of human neutrophil elastase (HNE) and proteinase-3, and weak inhibitors of human cathepsin G. The results herein presented show that the oxazolidine-2,4-diones represent a new promising class of serine protease inhibitors.
本文报道了恶唑烷-2,4-二酮类化合物的合成、对猪胰弹性蛋白酶(这里用作人中性粒细胞弹性蛋白酶的模型)的抑制活性和作用模式。恶唑烷-2,4-二酮骨架上 N 取代基的性质对弹性蛋白酶的抑制效力有很大影响。N-酰基和 N-磺酰基恶唑烷-2,4-二酮类化合物表现出强效的伪不可逆抑制剂,对 PPE 失活显示出高的二级速率常数。这些标题化合物也被证明是强效的人中性粒细胞弹性蛋白酶(HNE)和蛋白酶-3抑制剂,对人组织蛋白酶 G 的抑制作用较弱。本文的结果表明,恶唑烷-2,4-二酮类化合物代表了一类新的有前途的丝氨酸蛋白酶抑制剂。